Fig. 1: Flow-chart of the study participants.

A NHANES III cohort; B Kailuan cohort. MASLD metabolic dysfunction-associated steatotic liver disease, FBG fasting blood glucose, Hemoglobin A1c, HbA1c, eGFR estimated glomerular filtration rate, UACR urinary albumin to creatinine ratio.